|
注册号: Registration number: |
ChiCTR2200065885 |
|
最近更新日期: Date of Last Refreshed on: |
2023-05-04 08:57:53 |
|
注册时间: Date of Registration: |
2022-11-17 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
社区老年人认知筛查与随访:队列研究 |
|
Public title: |
Cognitive screening and follow-up of the elderly in community: a cohort study |
|
注册题目简写: |
社区老年人认知筛查与随访 |
|
English Acronym: |
Cognitive screening and follow-up of the elderly in community |
|
研究课题的正式科学名称: |
社区老年人认知筛查与随访:队列研究 |
|
Scientific title: |
Cognitive screening and follow-up of the elderly in community: a cohort study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张世芳 |
研究负责人: |
万巧琴 |
|
Applicant: |
Shifang Zhang |
Study leader: |
Qiaoqin Wan |
|
申请注册联系人电话: Applicant telephone: |
+86 15501125399 |
研究负责人电话:
Study leader's |
+86 13810690310 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
15501125399@163.com |
研究负责人电子邮件: Study leader's E-mail: |
qqwan05@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市海淀区学院路38号 |
研究负责人通讯地址: |
北京市海淀区学院路38号 |
|
Applicant address: |
38 Xueyuan Road, Haidian District, Beijing, China |
Study leader's address: |
38 Xueyuan Road, Haidian District, Beijing, China |
|
申请注册联系人邮政编码: Applicant postcode: |
100191 |
研究负责人邮政编码: Study leader's postcode: |
100191 |
|
申请人所在单位: |
北京大学护理学院 |
||
|
Applicant's institution: |
Peking University School of Nursing |
||
|
研究负责人所在单位: |
北京大学护理学院 |
||
|
Affiliation of the Leader: |
Peking University School of Nursing |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
IRB00001052-21166 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
北京大学生物医学伦理委员会 |
||
|
Name of the ethic committee: |
Institutional Review Board Office of Peking University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-02-24 00:00:00 | ||
|
伦理委员会联系人: |
宋艳双 |
||
|
Contact Name of the ethic committee: |
Yanshuang Song |
||
|
伦理委员会联系地址: |
北京市海淀区学院路38号 |
||
|
Contact Address of the ethic committee: |
38 Xueyuan Road, Haidian District, Beijing, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 10 82805751 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
北京大学护理学院 |
||||||||||||||||||||||
|
Primary sponsor: |
Peking University School of Nursing |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市海淀区学院路38号北京大学医学部 |
||||||||||||||||||||||
|
Primary sponsor's address: |
38 Xueyuan Road, Haidian District, Beijing, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
无 |
||||||||||||||||||||||
|
Source(s) of funding: |
N/A |
||||||||||||||||||||||
|
研究疾病: |
认知障碍 |
||||||||||||||||||||||
|
Target disease: |
Cognitive impairment |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
调查社区老年人认知功能、睡眠、身体功能及精神行为症状等情况,分析认知下降的轨迹,确定影响认知障碍发病和疾病进展的危险因素和保护因素,为未来临床和科研人员后续干预性研究提供参考和依据. |
||||||||||||||||||||||
|
Objectives of Study: |
To investigate the cognitive function, sleep, physical function and mental behavioral symptoms of the elderly in the community, analyze the track of cognitive decline, determine the risk factors and protective factors that affect the onset of cognitive impairment and disease progression, and provide reference and basis for future clinical and scientific researchers' follow-up intervention research. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
不适用 |
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
N/A |
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.有严重的精神疾病或其他严重器质性疾病,影响短期测评和诊断; |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Patients who have mental disorder or other serious organ diseases that affect the short-term prognosis of patients; 2. Patients with a history of mental disorders, drug addiction or other diseases cannot sign informed consent forms or cooperate with research trials. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-12-01 00:00:00至 To 2027-12-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-12-01 00:00:00 至 To 2023-12-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
不适用 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
N/A |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
文章公开发表后,如有需要可邮件联系。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
After the publication of the article, if there is any need to inform by email. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
纸质版认知测评记录表+电子采集管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF+EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |